highly significantp = 0.002
In contrast, thiazolidinedione use showed a highly significant association with glycemic control (χ2 = 9.918, p = 0.002), suggesting a potentially meaningful impact of this drug class on outcomes.
In contrast, thiazolidinedione use showed a highly significant association with glycemic control (χ2 = 9.918, p = 0.002), suggesting a potentially meaningful impact of this drug class on outcomes.
The use of meglitinides and phenylalanine analogues showed a trend toward significance (χ2 = 3.369, p = 0.066).
Sociodemographic determinants of glycemic control Although the association did not reach statistical significance, younger individuals (18-35 years) tended to exhibit poorer glycemic control than older patients.